Greystone Research Associates is pleased to announce the publication of a new
market study. Prefilled Syringes to 2018: Devices, Drugs, Markets, Players,
Prospects is a comprehensive evaluation and analysis of the technology,
products and participants providing the driving force behind this evolving
segment of the healthcare sector.
The study is designed to provide drug company decision makers, drug delivery
developers, device designers, healthcare marketers, and supply chain
participants with a detailed understanding of the economics, technologies,
disease segments, and commercial opportunities for prefilled syringes and
injectable devices. Provider organization business managers, healthcare
administrators and investors will also benefit from this study.
Prefilled Syringes and the Evolving Landscape for Injectable Drugs
The administration of therapeutic drugs via injection is an indispensable
delivery method for numerous drugs critical to patient health and well-being.
Now this segment is evolving in response to changing patient populations, new
classes of powerful therapeutic drugs and healthcare administration
initiatives. Population demographics and efforts by managed care providers to
control healthcare costs are driving the growth in drug self-administration,
particularly for chronic conditions, introducing a new class of naive users to
parenteral drug delivery. For Fill-and-Finish contractors, market proximity is
an important competitive factor. As the use of prefilled syringes continues to
grow, the issue of prefilled syringe safety has received increased attention,
with both integrated prefillable safety syringes and safety solutions designed
to accommodate existing prefillable syringes advancing commercially. This
report analyzes eleven important prefilled syringe therapeutic segments and
examines key regulatory, economic and competitive factors that represent
potential barriers to commercial success.
- Provides detailed analysis of prefilled syringe market segments, market
dynamics and market demographics
- Examines supply chain and ecosystem structure and relationships and their
impact on the competitive landscape
- Analyzes therapeutic demand drivers and evaluates commercial prefilled
syringe products in eleven major therapeutic segments
- Analyzes design factors, material selection issues, technologies and
market development issues
- Provides market data and forecasts to 2018
- Profiles injectable drug and device participants, their product
development activities, business strategies, and corporate alliances and
- Assesses the importance of pharma-device alliances and design partnerships
on prefilled syringe products
- Evaluates the impact of economic, technology, and regulatory factors
Research methodology is based on primary research in the form of in-depth
interviews with key market participants, technology developers, distributors,
industry experts, and market influencers, a list that includes regulatory
officials, industry trade groups, and materials standards organizations.
Primary data is evaluated and normalized against secondary sources including
trade journal articles, technical literature, industry publications, company
data sheets and published information, and statistical data from government
agencies and trade associations.
Forecasts and projections of market demand and future market activity are
derived using standard modeling and statistical techniques.